Spondyloarthropathy
Ankylosing spondylitis diagnosis, treatment based on a ‘constellation of symptoms’
Accurately diagnosing ankylosing spondylitis is a challenge for physicians, who must rely on a combination of symptoms and inflammation in place of a definitive blood marker.
Tofacitinib brings rapid clinical response in ankylosing spondylitis
Patients with ankylosing spondylitis demonstrated rapid clinical response to tofacitinib, which produced significantly greater efficacy than placebo, but with more adverse events, according to a speaker at ACR Convergence 2020.
Most VA rheumatologists consider telemedicine apt for regular patients with gout, RA, OA
At least 65% of rheumatologists at Veterans Affairs facilities view telemedicine as appropriate for established patients with gout, stable rheumatoid arthritis, osteoarthritis, stable spondyloarthritis and other diseases, researchers noted.
IL-17 inhibitors offer promising 'effective' treatment for ankylosing spondylitis
IL-17 inhibitors have recently demonstrated “quite effective” results in treating ankylosing spondylitis, according to a speaker at the 2020 Congress of Clinical Rheumatology-East.
FDA expands approval of ixekizumab for nonradiographic axial spondyloarthritis
The FDA has expanded the approval of ixekizumab injection 80 mg/mL to include treatment of active nonradiographic axial spondyloarthritis in patients with objective signs of inflammation.
MRI interpretation of suspected sacroiliitis varies greatly in children
There is a significant amount of variation and discordance among interpretations of inflammatory and structural lesions in sacroiliac joints among children, according to findings published in Arthritis Care & Research.
Spondyloarthritis in pregnancy linked to preterm birth, other adverse outcomes
Spondyloarthritis in pregnancy is associated with an increased risk for several adverse outcomes, including preterm birth, emergency cesarean section and epidural use, according to data published in Arthritis Care & Research.
Innovative clinical trial designs, therapies for refractory disease top unmet needs in rheumatology
New treatments and trial designs, particularly focused on patients with refractory disease, remain among the top unmet needs in rheumatology in 2019, according to expert opinions culled from the Advances in Target Therapies annual meeting and published in the Annals of the Rheumatic Diseases.
Gastroenterologist to rheumatologists: Suspect IBD more often
ATLANTA — Rheumatologists need to suspect inflammatory bowel disease more often in patients who present with joint pain, particularly in the presence of other clues, such as changes in bowel habits, bloody stool and unexplained weight loss, according to a presenter at ACR/ARP 2019.